Table 1.
Count | Age (range) ± SD | Male | Female | ||
---|---|---|---|---|---|
Nonprogressing | 46 | 56 (27–84) ±13 | |||
Low grade dysplasia* £ | 12 | 60 (43–84) ±14 | 7 | 4 | |
High grade dysplasia** £ | 18 | 60 (40–84) ±13 | 13 | 4 | |
Nondysplastic | 16 | 50 (27–69) ±10 | 12 | 4 | |
Progressing | 49 | 65 (29–93) ±13 | |||
Low grade dysplasia | 13 | 65 (48–93) ±13 | 6 | 7 | |
High grade dysplasia | 19 | 63 (29–87) ±14 | 13 | 6 | |
Nondysplastic *** | 17 | 68 (46–79) ±11 | 10 | 7 | |
OSCC | OSCC* | 50 | 66 (29–93) ±13 | 27 | 23 |
If one patient had multiple biopsies, age was considered at the time of taking each biopsy. Asterisks represent the number of patients missing age (* = 1, ** = 2, *** = 3). (£) represent the number of patients missing gender. Nondysplastic lesions include: hyperkeratosis = 18, nonspecific chronic inflammation = 8, nonspecific ulcer = 3, lichenoid inflammation = 2 and chronic inflammation and candidiasis = 2.